ImmunityBio, Inc. IBRX Segment Reporting — Other segment items
Discontinued — last reported Q4 '24
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: ImmunityBio, Inc.’s 10-K, filed March 3, 2025, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s segment reporting — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s segment reporting — other segment items?
- ImmunityBio, Inc. (IBRX) reported segment reporting — other segment items of $17.37M in Q4 2024.
- How has ImmunityBio, Inc.'s segment reporting — other segment items changed year-over-year?
- ImmunityBio, Inc.'s segment reporting — other segment items decreased by 68.7% year-over-year, from $55.4M to $17.37M.
- What is the long-term trend for ImmunityBio, Inc.'s segment reporting — other segment items?
- Over 2 years (2022 to 2024), ImmunityBio, Inc.'s segment reporting — other segment items has grown at a 2.6% compound annual growth rate (CAGR), from $66.02M to $69.46M.
- What does segment reporting — other segment items mean?
- A catch-all category for miscellaneous financial items specific to a business segment.
- How do you interpret segment reporting — other segment items?
- High volatility or large values may indicate non-recurring events or accounting adjustments that obscure the underlying operational performance of the segment.
- How does segment reporting — other segment items compare across companies?
- Similar to 'Other Operating Income/Expense' or 'Unallocated Corporate Expenses' found in segment reporting footnotes of peer companies.